EUVIMEDEUVIMED entdecken
Open Access

Pancreas transplantation improves the quality of life of Japanese type 1 diabetes patients with diabetic kidney disease

Chika Fujisawa-Tanaka, Izumi Hiratsuka, Megumi Shibata, Kei Kurihara, Naohiro Aida, Takeshi Takayanagi, Yusuke Seino, Taihei Ito, Takashi Kenmochi, Atsushi Suzuki

Fujita Medical Journal · 2023-08 · 9 (3) · 194-199

DOI: 10.20407/fmj.2022-019 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Fujita Medical Journal, 2023-08. Verfasst von Chika Fujisawa-Tanaka und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Endocrinology, Diabetes and Metabolism, Fujita Health University, School of Medicine, Toyoake, Aichi, Japan. Die Arbeit wurde bisher 2-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objectives

Type 1 diabetes mellitus (T1DM) patients with diabetic kidney disease-induced kidney failure have a significantly impaired quality of life (QOL), resulting in a high level of physical, mental, and social anxiety. In this study, we evaluated the QOL of T1DM patients on the list for pancreas transplantation (PTx) at their registration, and determined whether PTx improved their QOL.

Methods

There were 58 patients (men/women, 22/36; mean age, 42.8±8.0 years) with T1DM and who were registered on the waiting list for PTx. Quantitative QOL assessment was performed using the Medical Health Survey Short Form (SF-36) version 2. Changes in the QOL before and after PTx were also examined in 24 of these patients.

Results

The mean value of each endpoint and the summary score of the SF-36 physical (PCS), mental (MCS), and role (RCS) components were all below the national normal level at PTx registration. No significant difference in QOL scores was observed in the intergroup comparison of 35 patients on dialysis, 13 patients without dialysis, and ten patients after kidney transplantation. The 24 patients who underwent PTx showed improvement in PCS, MCS, and most SF-36 scores.

Conclusion

T1DM patients waiting for PTx had a decreased QOL, regardless of dialysis, and PTx improved their QOL.

Schlagwörter

Stichwörter der Autor:innen

Diabetic kidney diseasePancreas transplantationQuality of lifeType 1 diabetes mellitus

Autor:innen und Institutionen

  • Department of Endocrinology, Diabetes and Metabolism, Fujita Health University, School of Medicine, Toyoake, Aichi, Japan.
  • Department of Transplantation and Regenerative Medicine, Fujita Health University, School of Medicine, Toyoake, Aichi, Japan.

Zitieren

APA

Fujisawa-Tanaka, C., Hiratsuka, I., Shibata, M., Kurihara, K., Aida, N., Takayanagi, T., Seino, Y., Ito, T., Kenmochi, T., & Suzuki, A. (2023). Pancreas transplantation improves the quality of life of Japanese type 1 diabetes patients with diabetic kidney disease. Fujita Medical Journal, 9(3), 194-199. https://doi.org/10.20407/fmj.2022-019

Vancouver

Fujisawa-Tanaka C, Hiratsuka I, Shibata M, Kurihara K, Aida N, Takayanagi T, et al. Pancreas transplantation improves the quality of life of Japanese type 1 diabetes patients with diabetic kidney disease. Fujita Medical Journal. 2023;9(3):194-199. doi:10.20407/fmj.2022-019

BibTeX
@article{FujisawaTanaka2023,
  author = {Fujisawa-Tanaka, Chika and Hiratsuka, Izumi and Shibata, Megumi and Kurihara, Kei and Aida, Naohiro and Takayanagi, Takeshi and Seino, Yusuke and Ito, Taihei and Kenmochi, Takashi and Suzuki, Atsushi},
  title = {Pancreas transplantation improves the quality of life of Japanese type 1 diabetes patients with diabetic kidney disease},
  journal = {Fujita Medical Journal},
  year = {2023},
  volume = {9},
  number = {3},
  pages = {194--199},
  doi = {10.20407/fmj.2022-019}
}
Kostenlos starten →